Key result
Acute myocardial infarction in obstetric patients is a rare but rising event requiring modified diagnostic and therapeutic approaches due to physiological changes and contraindications in pregnancy.
Acute myocardial infarction in obstetric patients requires careful diagnostic consideration and modification of standard drug therapies due to pregnancy and breastfeeding contraindications.
Acute myocardial infraction (AMI) in the obstetric patient is a rare event, although the incidence is rising due to advancing maternal age and pre-existing cardiac risk factors and medical co-morbidities. While atherosclerotic disease is the leading cause of AMI, coronary artery dissection is an important consideration in pregnancy and in the postpartum period. The physiological changes of pregnancy as well as pregnancy-specific risk factors can predispose the obstetric patient to AMI. Diagnosis of AMI can be challenging as symptoms may be atypical. Furthermore, diagnostic tests must be interpreted in the context of pregnancy. While the overall management of the obstetric patient with AMI is similar to that outside of pregnancy, drug therapy requires modification as some medications may be contraindicated in pregnancy and breastfeeding. There is limited information about prognosis and risk stratification but it is anticipated that future studies will address this issue.
No takes yet. Share an insight, caveat, or question.
Firoz et al. (2012) conducted a review in Acute myocardial infarction in the obstetric patient. Acute myocardial infarction in obstetric patients is a rare but rising event requiring modified diagnostic and therapeutic approaches due to physiological changes and contraindications in pregnancy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: